Mark P. Healy

1.4k total citations
24 papers, 1.2k citations indexed

About

Mark P. Healy is a scholar working on Organic Chemistry, Pharmacology and Molecular Biology. According to data from OpenAlex, Mark P. Healy has authored 24 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Organic Chemistry, 8 papers in Pharmacology and 7 papers in Molecular Biology. Recurrent topics in Mark P. Healy's work include Inflammatory mediators and NSAID effects (8 papers), Synthesis and Biological Evaluation (6 papers) and Asymmetric Hydrogenation and Catalysis (5 papers). Mark P. Healy is often cited by papers focused on Inflammatory mediators and NSAID effects (8 papers), Synthesis and Biological Evaluation (6 papers) and Asymmetric Hydrogenation and Catalysis (5 papers). Mark P. Healy collaborates with scholars based in United Kingdom, United States and Switzerland. Mark P. Healy's co-authors include Timothy J. Donohoe, Di Shen, Darren L. Poole, Louis K. M. Chan, Laura M. Richards, Keith H. Gibson, Susan Ashton, Andrew A. Godfrey, Andrew Barker and Brenda J Curry and has published in prestigious journals such as Angewandte Chemie International Edition, Chemical Communications and Journal of Medicinal Chemistry.

In The Last Decade

Mark P. Healy

24 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark P. Healy United Kingdom 14 694 423 392 269 226 24 1.2k
Duen‐Ren Hou Taiwan 21 1.3k 1.9× 543 1.3× 560 1.4× 149 0.6× 66 0.3× 81 1.8k
Zhongzhi Wu United States 26 1.1k 1.6× 475 1.1× 337 0.9× 151 0.6× 33 0.1× 88 1.7k
Li‐Jun Xiao China 25 1.5k 2.2× 733 1.7× 323 0.8× 106 0.4× 86 0.4× 75 1.9k
Zhengjie He China 34 2.5k 3.6× 620 1.5× 642 1.6× 108 0.4× 58 0.3× 130 3.2k
Nozomu Sakai United States 21 1.0k 1.5× 752 1.8× 414 1.1× 152 0.6× 149 0.7× 33 1.8k
Hongfeng Li China 24 771 1.1× 160 0.4× 314 0.8× 124 0.5× 23 0.1× 65 1.6k
Bukeyan Miao China 16 522 0.8× 136 0.3× 602 1.5× 264 1.0× 122 0.5× 18 1.2k
Jesús Ramı́rez Spain 15 880 1.3× 241 0.6× 681 1.7× 429 1.6× 20 0.1× 21 1.5k
Hitesh J. Sanganee United Kingdom 23 741 1.1× 113 0.3× 592 1.5× 100 0.4× 21 0.1× 37 1.3k
Steven T. Staben United States 22 2.2k 3.2× 386 0.9× 617 1.6× 147 0.5× 18 0.1× 33 2.8k

Countries citing papers authored by Mark P. Healy

Since Specialization
Citations

This map shows the geographic impact of Mark P. Healy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark P. Healy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark P. Healy more than expected).

Fields of papers citing papers by Mark P. Healy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark P. Healy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark P. Healy. The network helps show where Mark P. Healy may publish in the future.

Co-authorship network of co-authors of Mark P. Healy

This figure shows the co-authorship network connecting the top 25 collaborators of Mark P. Healy. A scholar is included among the top collaborators of Mark P. Healy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark P. Healy. Mark P. Healy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gomez‐Mancilla, Baltazar, Ganesan Subramanian, Thomas Faller, et al.. (2023). MIJ821 (onfasprodil) in healthy volunteers: First‐in‐human, randomized, placebo‐controlled study (single ascending dose and repeated intravenous dose). Clinical and Translational Science. 16(11). 2236–2252. 7 indexed citations
2.
Healy, Mark P., Andy Billinton, Iain P. Chessell, et al.. (2018). Discovery of {4-[4,9-bis(ethyloxy)-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl]-2-fluorophenyl}acetic acid (GSK726701A), a novel EP4 receptor partial agonist for the treatment of pain. Bioorganic & Medicinal Chemistry Letters. 28(10). 1892–1896. 4 indexed citations
3.
Shaw, Duncan, et al.. (2017). Interactions between β2-Adrenoceptor Ligands and Membrane: Atomic-Level Insights from Magic-Angle Spinning NMR. Journal of Medicinal Chemistry. 60(16). 6867–6879. 3 indexed citations
4.
Auberson, Yves P., Emmanuelle Briard, David A. Sykes, John Reilly, & Mark P. Healy. (2016). Ligand Specific Efficiency (LSE) Index for PET Tracer Optimization. ChemMedChem. 11(13). 1415–1427. 21 indexed citations
5.
Shen, Di, et al.. (2014). Hydrogen‐Borrowing and Interrupted‐Hydrogen‐Borrowing Reactions of Ketones and Methanol Catalyzed by Iridium. Angewandte Chemie. 127(5). 1662–1665. 36 indexed citations
6.
Shen, Di, et al.. (2014). Hydrogen‐Borrowing and Interrupted‐Hydrogen‐Borrowing Reactions of Ketones and Methanol Catalyzed by Iridium. Angewandte Chemie International Edition. 54(5). 1642–1645. 156 indexed citations
7.
Chan, Louis K. M., Darren L. Poole, Di Shen, Mark P. Healy, & Timothy J. Donohoe. (2013). Rhodium‐Catalyzed Ketone Methylation Using Methanol Under Mild Conditions: Formation of α‐Branched Products. Angewandte Chemie. 126(3). 780–784. 58 indexed citations
8.
Chan, Louis K. M., Darren L. Poole, Di Shen, Mark P. Healy, & Timothy J. Donohoe. (2013). Rhodium‐Catalyzed Ketone Methylation Using Methanol Under Mild Conditions: Formation of α‐Branched Products. Angewandte Chemie International Edition. 53(3). 761–765. 220 indexed citations
9.
10.
Chapman, Paul B., Gerard M.P. Giblin, Mark P. Healy, et al.. (2011). Discovery of GSK1997132B a novel centrally penetrant benzimidazole PPARγ partial agonist. Bioorganic & Medicinal Chemistry Letters. 21(18). 5568–5572. 20 indexed citations
11.
Whitwood, Adrian C., et al.. (2010). Remarkable anion effects uncovered in the development of a Au(iii)-catalyzed tandem nucleophilic substitution–1,5-enyne cycloisomerization process. Chemical Communications. 46(12). 2046–2046. 24 indexed citations
12.
Healy, Mark P., Gianpaolo Bravi, Andrew Billinton, et al.. (2010). Pyrazolopyridazine alpha-2-delta-1 ligands for the treatment of neuropathic pain. Bioorganic & Medicinal Chemistry Letters. 20(15). 4683–4688. 12 indexed citations
13.
14.
Hall, Adrian, Susan H. Brown, A. R. Chowdhury, et al.. (2007). Identification and optimization of novel 1,3,4-oxadiazole EP1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 17(16). 4450–4455. 16 indexed citations
15.
Hall, Adrian, Susan H. Brown, Iain P. Chessell, et al.. (2006). 1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists: Structure–activity relationships of 4- and 5-substituted benzoic acid derivatives. Bioorganic & Medicinal Chemistry Letters. 17(3). 732–735. 9 indexed citations
16.
Hall, Adrian, Stephen J. Atkinson, Susan H. Brown, et al.. (2006). Structure–activity relationships of 1,5-biaryl pyrroles as EP1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 16(14). 3657–3662. 21 indexed citations
17.
McKeown, Stephen C., Adrian Hall, Susan H. Brown, et al.. (2006). Identification of novel glycine sulfonamide antagonists for the EP1 receptor. Bioorganic & Medicinal Chemistry Letters. 17(6). 1750–1754. 13 indexed citations
18.
Hall, Adrian, Susan H. Brown, Iain P. Chessell, et al.. (2006). 1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists. Structure–activity relationships of 6-substituted and 5,6-disubstituted benzoic acid derivatives. Bioorganic & Medicinal Chemistry Letters. 17(4). 916–920. 12 indexed citations
19.
Hall, Adrian, Stephen J. Atkinson, Susan H. Brown, et al.. (2006). Discovery of novel, non-acidic 1,5-biaryl pyrrole EP1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 17(5). 1200–1205. 38 indexed citations
20.
Page, Philip C. Bulman, Donald Bethell, Paul A. Stocks, et al.. (2000). Sulfur Oxidation Mediated by Imine Derivatives. Synlett. 12(12). 1355–1358. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Duen‐Ren Hou Breakdown of academic impact, for papers by Zhongzhi Wu Breakdown of academic impact, for papers by Li‐Jun Xiao Breakdown of academic impact, for papers by Zhengjie He Breakdown of academic impact, for papers by Nozomu Sakai Breakdown of academic impact, for papers by Hongfeng Li Breakdown of academic impact, for papers by Bukeyan Miao Breakdown of academic impact, for papers by Jesús Ramı́rez Breakdown of academic impact, for papers by Hitesh J. Sanganee Breakdown of academic impact, for papers by Steven T. Staben
Rankless by CCL
2026